CVS HEALTH Corp (CVS) — SEC Filings

Latest SEC filings for CVS HEALTH Corp (CVS), explained in plain English.

Sentiment Overview: 1 bullish, 1 bearish, 38 neutral, 2 mixed

Recent Filings (42)

• 8-K Filing — 8-K · 2025-12-09T00:00:00.000Z [neutral]
• CVS Health Files 8-K Report — 8-K · 2025-11-20T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K report on November 20, 2025, to disclose information regarding other events and financial statements. The filing does not co
• 13F-HR Filing — 13F-HR · 2025-10-31T00:00:00.000Z [neutral]
• CVS Plunges to $3.99B Loss on Massive Goodwill Impairment — 10-Q · 2025-10-29T00:00:00.000Z [bearish] Risk: high
  CVS Health Corporation reported a significant net loss of $3.99 billion for the three months ended September 30, 2025, a stark contrast to the net income of $71
• CVS Health Files 8-K Report — 8-K · 2025-09-22T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on September 22, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific detail
• CVS Health Files 8-K Report — 8-K · 2025-08-15T00:00:00.000Z [neutral] Risk: low
  On August 11, 2025, CVS Health Corporation filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. No specific new ma
• 13F-HR Filing — 13F-HR · 2025-08-01T00:00:00.000Z [neutral]
• CVS Health Q2 Revenue Jumps to $92.4B, Driven by Product & Service Growth — 10-Q · 2025-07-31T00:00:00.000Z [bullish] Risk: medium
  CVS Health Corp reported robust financial performance for the second quarter ended June 30, 2025, with total revenues reaching $92.4 billion, marking a signific
• CVS Health Files 8-K on Shareholder Votes — 8-K · 2025-05-20T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on May 20, 2025, reporting on matters submitted to a vote of security holders as of May 15, 2025. The filing details the com
• 13F-HR Filing — 13F-HR · 2025-05-02T00:00:00.000Z [neutral]
• CVS Health Q1 2025 Filing: Financial Snapshot — 10-Q · 2025-05-01T00:00:00.000Z [neutral] Risk: low
  CVS Health Corp. reported its first quarter 2025 results for the period ending March 31, 2025. The company's filing details its financial performance, including
• CVS Health Corp. Files 8-K: Officer/Director Changes & Compensation Updates — 8-K · 2025-04-08T00:00:00.000Z [neutral] Risk: low
  On April 7, 2025, CVS Health Corporation filed an 8-K report detailing the departure of certain officers and directors, the election of new directors, and updat
• CVS Health Files 2025 Proxy Statement — DEF 14A · 2025-04-04T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed its DEF 14A proxy statement on April 4, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensati
• 13F-HR Filing — 13F-HR · 2025-02-13T00:00:00.000Z [neutral]
• CVS Health Files 2024 10-K — 10-K · 2025-02-12T00:00:00.000Z [neutral] Risk: medium
  CVS Health Corp. filed its 2024 10-K on February 12, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as CVS Caremark
• CVS Health Files 8-K — 8-K · 2024-12-17T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on December 16, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing details the company's pri
• CVS Health Files 8-K Report — 8-K · 2024-12-10T00:00:00.000Z [neutral] Risk: low
  On December 10, 2024, CVS Health Corporation filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific
• CVS Health Files 8-K with Corporate Details — 8-K · 2024-12-09T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on December 9, 2024, reporting other events and financial statements. The filing details the company's principal executive o
• CVS Health Files 8-K: Other Events & Financials — 8-K · 2024-12-06T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on December 6, 2024, reporting other events and financial statements. The filing does not contain specific details on new tr
• CVS Health Files 8-K — 8-K · 2024-12-05T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on December 5, 2024, reporting an event that occurred on December 3, 2024. The filing is categorized under 'Other Events' an
• CVS Health Files 8-K with Corporate Details — 8-K · 2024-12-02T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on December 2, 2024, reporting other events and financial statements. The filing details the company's principal executive o
• CVS Health CLO Departs, New CLO Appointed — 8-K · 2024-11-18T00:00:00.000Z [neutral] Risk: medium
  CVS Health Corporation announced on November 12, 2024, the departure of its Chief Legal Officer, Thomas R. Robinson, effective November 15, 2024. The company al
• SC 13G Filing — SC 13G · 2024-11-13T00:00:00.000Z [neutral]
• 13F-HR Filing — 13F-HR · 2024-11-08T00:00:00.000Z [neutral]
• CVS Health Files 8-K: Director Changes & Executive Compensation — 8-K · 2024-11-06T00:00:00.000Z [neutral] Risk: medium
  On November 6, 2024, CVS Health Corporation filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes info
• CVS Health Files Q3 2024 10-Q — 10-Q · 2024-11-06T00:00:00.000Z [neutral] Risk: low
  CVS Health Corp. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter of 2024 and provides financial updates for the com
• SC 13G/A Filing — SC 13G/A · 2024-10-24T00:00:00.000Z [neutral]
• CVS Health Files 8-K on Operations and Personnel — 8-K · 2024-10-18T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on October 18, 2024, reporting on events that occurred on October 17, 2024. The filing covers results of operations, financi
• 13F-HR Filing — 13F-HR · 2024-08-09T00:00:00.000Z [neutral]
• CVS Health Files Q2 2024 10-Q — 10-Q · 2024-08-07T00:00:00.000Z [neutral] Risk: low
  CVS Health Corp. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of
• CVS Health Reports Director/Officer Changes & Shareholder Votes — 8-K · 2024-05-22T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on May 22, 2024, reporting events that occurred on May 16, 2024. The filing primarily concerns the departure of directors or
• CVS Health Files 8-K: Corporate Details Updated — 8-K · 2024-05-09T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on May 9, 2024, reporting other events and financial statements. The filing details the company's principal executive office
• CVS Health Files 8-K: Other Events & Financials — 8-K · 2024-05-08T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed an 8-K on May 7, 2024, reporting other events and financial statements. The filing details the company's principal executive office
• 13F-HR Filing — 13F-HR · 2024-05-03T00:00:00.000Z [neutral]
• CVS Health Files Q1 2024 10-Q — 10-Q · 2024-05-01T00:00:00.000Z [neutral] Risk: low
  CVS Health Corp. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance for the first quarter of 2024, comparing it to th
• CVS Health Files 2024 Proxy Statement — DEF 14A · 2024-04-05T00:00:00.000Z [neutral] Risk: low
  CVS Health Corporation filed its DEF 14A proxy statement on April 5, 2024, for the fiscal year ending December 31, 2023. The filing details executive compensati
• CVS Health Files 8-K Report — 8-K · 2024-03-05T00:00:00.000Z [neutral] Risk: low
  On March 5, 2024, CVS Health Corporation filed an 8-K report. The filing primarily serves as a notification of events and does not disclose specific new financi
• Vanguard Amends CVS Health Stake, Remains Passive Investor — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral] Risk: low
  The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, indicating its ownership of CVS Health Corp common stock as of Dece
• 07 Trade & Services Boosts LUMIRADX, Adds Vanguard & iShares ETFs — 13F-HR · 2024-02-09T00:00:00.000Z [mixed] Risk: medium
  CVS Health Corp's 13F-HR filing for the period ending December 31, 2023, reveals that 07 Trade & Services, an investment manager, significantly increased its ho
• CVS Health Files 2023 10-K, Details Financial Performance — 10-K · 2024-02-07T00:00:00.000Z [neutral]
  CVS Health Corp. filed its 10-K on February 7, 2024, for the fiscal year ending December 31, 2023. This filing provides a comprehensive look at the company's fi
• BlackRock Amends CVS Health Stake, Signals Portfolio Shift — SC 13G/A · 2024-01-26T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating a change in their ownership of CVS Health Corp. common stock as of December 31, 2023. T
• CVS Health 8-K Hints at Financials, Officer Changes, Reg FD Disclosure — 8-K · 2024-01-05T00:00:00.000Z [mixed]
  CVS Health Corp filed an 8-K on January 5, 2024, indicating that it is reporting on "Results of Operations and Financial Condition," "Departure of Directors or